Edition:
United Kingdom

Deciphera Pharmaceuticals Inc (DCPH.OQ)

DCPH.OQ on NASDAQ Stock Exchange Global Select Market

20.65USD
19 Jul 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$20.65
Open
$20.65
Day's High
$21.13
Day's Low
$20.50
Volume
79,252
Avg. Vol
76,051
52-wk High
$41.00
52-wk Low
$18.56

About

Deciphera Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is developing drugs to improve the lives of cancer patients. Its drug candidate includes DCC-2618, DCC-3014 and Rebastinib. Its proprietary kinase switch control inhibitor platform, inhibit the activation of kinases. DCC-2618, an orally... (more)

Overall

Beta: --
Market Cap(Mil.): $702.77
Shares Outstanding(Mil.): 30.68
Dividend: --
Yield (%): --

Financials

  DCPH.OQ Industry Sector
P/E (TTM): -- 69.41 32.67
EPS (TTM): -1.08 -- --
ROI: -- 8.94 14.49
ROE: -- 10.07 15.79

Earnings vs. Estimates